Coagulation tests in septic surgical patients;Koagulacijski testovi u sepsi kirurških bolesnika: Kohortna studija

Acta Medica Croatica

Volumn 58, Issue 5, 2004, Pages 389-393

  Oberhoter, Dagmar ^a,b   Kucisec Tepes N ^a   Skok, J ^a   Vucic N ^b   Cala K ^b  

^a Department of Anesthesiology and Intensive Care ^*  (Croatia)

^b University Hospital Sveti Duh   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD; BLOOD CLOTTING TEST; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; SEPSIS; SURGERY; SURVIVAL RATE;

ADULT; AGED; BLOOD COAGULATION TESTS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEPSIS; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL RATE;

EID: 15744361994     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Salyers AA, Whitt DD. Virulence factors that damage the host. U: Salyers AA, Whitt DD. Bacterial Pathogenesis: A Molecular Approach. Washington, DC-ASM Press, 1994, 47-60.
2. Schmitt CK, Mwsick KC, O'Brien AD. Bacterial toxins: friends or foes? Emerg Infect Dis 1999; 5: 224-40.
3. Granato PA. Pathogenic and indigenous microorganisms of humans. U: Munay PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Manual of Clinical Microbiol, ogy. 8th ed. Washington, DC: ASM Press, 2003, 44-54.
4. Levi M. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient. J Crit Care 2001; 16: 167-77.
5. Ten Cate H. Pathophysiology of disseminated intravascular coagulation in sepsis. Crit Care Med 2000; 28;9-11.
6. Dhainaut JF, Yan SB, Cariou A, Mira JP. Soluble tluombomodulin, plasma-derived inactivated protein C, and recombinant human activated protein C in sepsis. Crit Care Med 2002; 30: 318-24.
7. Kaplan KL Coagulation activation in sepsis. Crit Care Med 2000; 28: 451-7.
8. Esmon CT, Fukdome K Mather T i sur. Inflammation, sepsis, and coagulation. Haematolopca 1999; 84: 254-9.
9. Vervoet MG, Thijs LG, Hade CE Derangements of coagulation and fibrinolysis in critkally ill patients with sepsis and septic shock Semin Thromb Hemost 1998; 24: 33-44.
10. Pilz G, Fraunberger P, Appel R i sur. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis. Crit Care Med 1996; 24: 596-600.
11. Bernard GR, Hy EW, Wright TJ i sur. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med 2001; 29: 2051-9.
12. Bernard G, Artigas A, Dellinger P i sur. Clinical Expert round table discussion (session 3) at the Margaux Conference on Critical Illness: the role of activated protein C in severe sepsis. Crit Care Med 2001; 29: 75-7.
13. Rintala E, Kauppila M, Seppala OP i sur. Protein C substitution in sepsis-assodated purpura fulminans. Crit Care Med 2000; 28: 2373-8.
14. De Gasperi A Severe sepsis, inflammation and coagulation: a close connection between physiological anticoagulants and improved prognosis. Minerva Anesthesiol 2000; 66: 1-2
15. Boldt J, Papsdorf M, Rothe A, Kumle B, Piper S. Changes of the hemostatic network in critically ill patients - is there a difference between sepsis, trauma, and neurosurgery patients? Crit Care Med 2000; 28: 445-50.
16. Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of extrinsic coagulation pathway in patients with severe sepsis and septic shock Crit Care Med 1998; 26: 2005-9.
17. Chen FG, Koh KF. Septic shock in surgical intensive care-validation of multiorgan and APACHE II scores in predicting outcome. Ann Acad Med Singapore 1994; 23: 447-51.
18. Schroder J, Kahlke V, Staubach KH, Zabel P, Stu-ber F. Gender differences in human sepsis. Arch Surg 1998; 133: 1200-5.
19. Ten Cate H, Schoenmakers SH, Franco R, Tim-merman JJ, Groot AP, Reitsma PH. Microvascular coagulopathy and disseminated intravascular coagulation. Crit Care Med 2001; 29: 95-7.
20. Lee WL, Downey GP. Coagulation inhibitors in sepsis and disseminated intravascular coagulation. Int Care Med 2000; 26: 1701-6.
21. Hack CE. Fibrinolysis in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 633-8.
22. Vallet B, Wiel E. Endothelial cell dyshinction and coagulation. Crit Care Med 2001; 29: 36-41.
23. Aird WC. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med 2001; 29: 28-34.
24. Creasey AA, Reinhart K. Tissue factor pathway inhibitor activity in severe sepsis. Crit Care Med 2001; 29: 107-8.
25. Grando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory disease syndrome in patients with trauma and sepsis. J Trauma-Injury Infect Crit Care 1999; 47: 719-23.
26. Asakura H, Ontachi Y, Mizutani T i sur. Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular -coagulation. Eur J Haematol 2001; 67: 170-5.
27. Asakura H, Ontachi Y, Mizutani T i sur. Decreased plasma activity of plasminogen or a2-plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2001; 12: 275-81.
28. Biron C, Bengler C, Gris JC, Schaved JF. Acquired isolated factor VII defidency during sepsis. Haemostasis 1997; 27: 51-6.
29. Faust SN, Heyderman RS, Levin M. Coagulation in severe sepsis: a central role for thrombomodulin ad activated protein C. Crit Care Med 2001; 29: 62-7.
30. Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001; 29: 48-51.
31. Dhainaut JF, Marin N, Mignon A, Vinsonneau C. Hepatic response to sepsis: interaction between coagulation and inflammatoiy processes. Crit Care Med 2001; 29: 42-7.
32. White B, Peny D. Acquired antithrombin deficiency in sepsis. Br J Haematol 2001; 112: 26-31.
33. Levi M, de Jonge E, van der Poll T. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med 2001; 29: 90-4.